Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
4.960
+0.320 (6.90%)
Nov 21, 2024, 1:31 PM EST - Market open

Fennec Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
49.3521.251.54-0.17-
Upgrade
Revenue Growth (YoY)
278.09%1284.50%----
Upgrade
Cost of Revenue
3.21.260.09---
Upgrade
Gross Profit
46.1519.991.45-0.17-
Upgrade
Selling, General & Admin
44.1832.7120.5112.2412.957.4
Upgrade
Research & Development
0.290.063.534.985.115.61
Upgrade
Operating Expenses
44.4632.7624.0417.2218.0613.01
Upgrade
Operating Income
1.68-12.77-22.59-17.22-17.89-13.01
Upgrade
Interest Expense
-4.15-3.68-1.13-0.14-0.41-0.06
Upgrade
Interest & Investment Income
1.40.440.20.050.090.32
Upgrade
Currency Exchange Gain (Loss)
-0.050.01-0.01-0.01--
Upgrade
Other Non Operating Income (Expenses)
------0.02
Upgrade
EBT Excluding Unusual Items
-1.12-16.01-23.53-17.32-18.21-12.78
Upgrade
Gain (Loss) on Sale of Investments
-0.01-0.04-0.18-0.030.1-
Upgrade
Pretax Income
-1.13-16.05-23.71-17.35-18.11-12.78
Upgrade
Net Income
-1.13-16.05-23.71-17.35-18.11-12.78
Upgrade
Net Income to Common
-1.13-16.05-23.71-17.35-18.11-12.78
Upgrade
Shares Outstanding (Basic)
272726262420
Upgrade
Shares Outstanding (Diluted)
272726262420
Upgrade
Shares Change (YoY)
2.34%1.14%1.03%9.71%19.14%5.04%
Upgrade
EPS (Basic)
-0.04-0.60-0.90-0.67-0.76-0.64
Upgrade
EPS (Diluted)
-0.04-0.60-0.90-0.67-0.76-0.64
Upgrade
Free Cash Flow
23.59-17.14-18.06-14.22-15.6-9.06
Upgrade
Free Cash Flow Per Share
0.87-0.65-0.69-0.55-0.66-0.46
Upgrade
Gross Margin
93.52%94.08%94.40%-100.00%-
Upgrade
Operating Margin
3.41%-60.09%-1471.60%--10520.59%-
Upgrade
Profit Margin
-2.30%-75.50%-1544.89%--10652.35%-
Upgrade
Free Cash Flow Margin
47.81%-80.67%-1176.42%--9173.53%-
Upgrade
EBIT
1.68-12.77-22.59-17.22-17.89-13.01
Upgrade
EBIT Margin
3.41%-60.09%----
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.